EUVIMEDEUVIMED entdecken
Crossref

Depression as a Predictor of Opioid Use Disorder in Sickle Cell Disease Patients

umar Usman, YAKUBU ANAS, Bakare Abdulfatai, Sani Abubakar, Abubakar Ahmad, Bello Amira, Abdullahi Uzairu, zakariyya Abdurrahman, Abdulaziz Mohammad, Sanusi Abdallah, Aliyu Ladan, Habibu Abubakar und 3 weitere

Journal of Medical Research and Reviews · 2024 · 1

DOI: 10.5455/jmrr.20240901020050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Research and Reviews, 2024. Verfasst von umar Usman und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sickle cell disease (SCD) is highly prevalent in Africa, especially in Nigeria, the most populous country, and is associated with a high mortality rate. Depression, common among individuals with SCD, correlates with increased pain intensity and opioid misuse, leading to poorer outcomes and diminished quality of life in these patients. AIM: To determine whether major depressive disorder is a predictor of opioid use disorder among patients with sickle cell disease. MATERIALS AND METHODS: This cross-sectional study was conducted at UDUTH Sokoto and employed psychometric instruments to evaluate patients with SCD. A systematic sampling technique was utilized, and data analyzed using SPSS version 25. Chi-square tests and regression analysis were employed to assess associations and identify predictors, respectively. RESULTS: The study found statistically significant associations between opioid use disorder (OUD) and the lack of insurance services (p-value = 0.008), major depressive disorder (p-value < 0.001), and elevated pain scores (p-value = 0.003), but not with hemoglobin type (p-value = 0.229). OUD was also more prevalent among respondents with moderate to severe depression (p-value = 0.017). However, only major depressive disorder was identified as a predictor of OUD (AOR: 0.174, 95% CI: 0.067–0.452, p-value < 0.001). CONCLUSION: The study identified major depressive disorder as a predictor of OUD among patients with SCD, this underscores the necessity for routine depression screening and timely intervention in this population. Keywords: Major depressive disorder, Opioid use disorder, Sickle cell disease.

Zitieren

APA

Usman, U., ANAS, Y., Abdulfatai, B., Abubakar, S., Ahmad, A., Amira, B., Uzairu, A., Abdurrahman, Z., Mohammad, A., Abdallah, S., Ladan, A., Abubakar, H., Bashir, U., Sarki, J., & Ibrahim, A. (2024). Depression as a Predictor of Opioid Use Disorder in Sickle Cell Disease Patients. Journal of Medical Research and Reviews, 1. https://doi.org/10.5455/jmrr.20240901020050

Vancouver

Usman U, ANAS Y, Abdulfatai B, Abubakar S, Ahmad A, Amira B, et al. Depression as a Predictor of Opioid Use Disorder in Sickle Cell Disease Patients. Journal of Medical Research and Reviews. 2024:1. doi:10.5455/jmrr.20240901020050

BibTeX
@article{Usman2024,
  author = {Usman, umar and ANAS, YAKUBU and Abdulfatai, Bakare and Abubakar, Sani and Ahmad, Abubakar and Amira, Bello and Uzairu, Abdullahi and Abdurrahman, zakariyya and Mohammad, Abdulaziz and Abdallah, Sanusi and Ladan, Aliyu and Abubakar, Habibu and Bashir, Umar and Sarki, Junaidu and Ibrahim, Abdulaziz},
  title = {Depression as a Predictor of Opioid Use Disorder in Sickle Cell Disease Patients},
  journal = {Journal of Medical Research and Reviews},
  year = {2024},
  number = {0},
  pages = {1},
  doi = {10.5455/jmrr.20240901020050}
}
Kostenlos starten →